Showing results (191-200 of 281) with videos related to

Sort By:
Pageof 29
Pharmacogenetics|April 20, 1999
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populationsE S Collie-Duguid, S C Pritchard, R H Powrie, et al.
British Journal of Cancer|February 24, 1998
Characterization of dihydropyrimidine dehydrogenase in human colorectal tumoursH L McLeod, J Sludden, G I Murray, et al.
British Journal of Cancer|March 1, 2002
c-erbB-2 is not a major factor in the development of colorectal cancerJ A McKay, J F Loane, V G Ross, et al.
Clinical Pharmacology and Therapeutics|August 31, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosingK E Caudle, C F Thorn, T E Klein, et al.
The Pharmacogenomics Journal|July 22, 2015
Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trialY J He, S J Winham, J M Hoskins, et al.
International Journal of Cancer|October 23, 2001
Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancerE S Collie-Duguid, S J Johnston, L Boyce, et al.
International Journal of Oncology|June 15, 2000
Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomasJ A McKay, C Lloret, G I Murray, et al.
The Pharmacogenomics Journal|December 6, 2017
Gene expression and linkage analysis implicate CBLB as a mediator of rituximab resistanceJ Jack, G W Small, C C Brown, et al.
Oncology Reports|March 8, 2007
PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancerW T Lim, W H Zhang, C R Miller, et al.
Leukemia|August 4, 2007
Genome scan implicates adhesion biological pathways in secondary leukemiaC Hartford, W Yang, C Cheng, et al.
Pageof 29